TI
HCAT icon

Trexquant Investment’s Health Catalyst HCAT Stock Holding History

Trexquant Investment’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-136,810
Closed -$1.11M – 1669
2024
Q3 		$1.11M Sell
136,810
-119,594
-47% -$864K 0.01% 1014
2024
Q2 		$1.64M Buy
256,404
+175,012
+215% +$1.12M 0.03% 820
2024
Q1 		$613K Buy
81,392
+18,984
+30% +$173K 0.01% 1087
2023
Q4 		$578K Sell
62,408
-79,123
-56% -$647K 0.01% 1023
2023
Q3 		$1.43M Buy
141,531
+113,423
+404% +$1.35M 0.04% 608
2023
Q2 		$351K Sell
28,108
-33,259
-54% -$396K 0.01% 1140
2023
Q1 		$716K Sell
61,367
-37,591
-38% -$479K 0.02% 863
2022
Q4 		$1.05M Buy
+98,958
New +$955K 0.03% 623
2021
Q2 		– Sell
-6,403
Closed -$299K – 1258
2021
Q1 		$299K Sell
6,403
-8,431
-57% -$408K 0.03% 753
2020
Q4 		$646K Buy
+14,834
New +$547K 0.07% 364
2020
Q3 		– Sell
-23,175
Closed -$676K – 1338
2020
Q2 		$676K Buy
+23,175
New +$640K 0.05% 550

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Trexquant Investment's HCAT Position: Q4 2024 in Review

Trexquant Investment sold out of Health Catalyst (HCAT) in Q4 2024, closing a stake of 136,810 shares — an estimated $1.11M sold.

Trexquant Investment first reported a position in HCAT in Q2 2020 and held it in 11 quarters. The position peaked at $1.64M in Q2 2024. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2024.

  • Trexquant Investment reported no remaining Health Catalyst position as of Q4 2024 after selling out during the quarter.
  • Trexquant Investment sold 136,810 Health Catalyst shares in Q4 2024, an estimated $1.11M.
  • Trexquant Investment first reported a position in Health Catalyst in Q2 2020 and held it in 11 quarters.
  • Trexquant Investment's Health Catalyst position peaked at $1.64M in Q2 2024.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.